Back

Proteomic screening using NGS-based method identifies cardiovascular diseases biomarkers in patients without cardiovascular disease but with glucose metabolism disturbances.

3 April 2025 (14:30 - 15:15)
Organised by: Logo
Congress Presentation Part of: Managing diabetes and glucose metabolism Metabolic Syndrome, Insulin, Insulin Resistance EAPC Premium Access ESC Preventive Cardiology 2025 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Professor Karol Kaminski

Medical University of Bialystok, Bialystok (Poland)

5 More presentations in this session

Presentation thumbnail
Exploring the preventive role of GLP-1 receptor agonists in reducing pulmonary hypertension in diabetes: a multimodal analysis
Doctor A. Albulushi (Muscat, OM)
Abstract Slides
Presentation thumbnail
Effect of SGLT2 inhibitors on temporal change of skeletal muscle index in patients with outpatient cardiac rehabilitation program
Doctor M. Kanazawa (Morioka, JP)
Abstract Slides
Presentation thumbnail
Application and usability of telemonitoring devices and Apps for patients with heart failure and diabetes type II.
Doctor S. Scalvini (Lumezzane, IT)
Abstract Slides
Presentation thumbnail
Non-invasive continuous glucose monitoring in patients without diabetes: use in cardiovascular prevention - a systematic review
Ms G. Petrasch (Davos Wolfgang, CH)
Abstract Slides
Presentation thumbnail
Deciphering the effect of exercise timing on glucose metabolism: a randomised controlled trial
Ms F. Bruggisser (Basel, CH)
Abstract Slides

Access the full session

Session thumbnail
Managing diabetes and glucose metabolism

The Event

Event poster

ESC Preventive Cardiology 2025

3 April 2025 14:30 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources